Optum Rx has announced it will drop prior authorization for an estimated 80 drugs starting May 1.
The program targets reauthorizations of drugs. For instance, once a genetic condition such as cystic fibrosis is confirmed through testing, there is minimal additional value in reauthorizing an effective, lifelong treatment, said Optum Rx.
The list of drugs is expected to be expanded over time.
WHY THIS MATTERS
